Christopher Jackson

Secured the reversal of a $41 million jury verdict in a case involving contract and tort claims arising out of a natural resources development project.

Successfully reduced a jury verdict by several million dollars in post-trial motions on a 42 U.S.C. § 1983 claim against a municipal defendant.

Successfully represented a number of organizational clients in Title Board appeals before the Colorado Supreme Court.

Successfully defended a district court judgment in a sprawling intellectual property matter before both the Federal Circuit and the US Supreme Court.

Currently serving as lead appellate counsel in an interlocutory appeal involving a multi-million dollar international business tort dispute.

Successfully defended an appellate challenge in a bid protest matter worth several hundred million dollars before the Federal Circuit.

Obtained a reversal in a high-profile business licensing dispute by convincing the court that the government agency misapplied settled law.

Successfully defended a judgment confirming a significant arbitration award against an international mining operation.

Served as appellate counsel successfully defending against a $92 million lawsuit arising out of an international hydrocarbon development project. Obtained reversal of the original $42 million judgment on appeal, and then a complete defense verdict following a six-day jury trial.

Successfully first chaired a week-long jury trial in a dispute over a real estate agreement.

Served as general counsel for the campaign committee of a candidate for statewide office.

Served as general counsel for the transition committee of a statewide elected official.

Secured summary judgment in a series of intellectual property actions involving a medical device manufacturer in three federal districts.

Trial counsel for a national franchise in a trademark dispute that settled on favorable terms.

Currently representing a municipal entity in a dispute worth millions over indemnification rights.

Obtained a highly favorable settlement after several weeks of trial in an antitrust case against a pharmaceutical company.